• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Gln (c.743G>A); ClinVar=VCV000012356; Zygosity=Homozygous (from parent cell line).
  

PubMed=22358567; DOI=10.1007/BF00146816
Shinji Hosoi, Hiroyuki Mioh, Chigusa Anzai, Seiji Sato, Nobuo Fujiyoshi;
Establishment of Namalva cell lines which grow continuously in glutamine-free medium.
Cytotechnology 1:151-158(1988)

PubMed=1366592; DOI=10.1007/BF00143675
Hiromasa Miyaji, Tamio Mizukami, Shinji Hosoi, Seiji Sato, Nobuo Fujiyoshi, Seiga Itoh;
Expression of human beta-interferon in Namalwa KJM-1 which was adapted to serum-free medium.
Cytotechnology 3:133-140(1990)

PubMed=1369278; DOI=10.1007/BF00148809
Hiromasa Miyaji, Nahoko Harada, Tamio Mizukami, Seiji Sato, Nobuo Fujiyoshi, Seiga Itoh;
Expression of human lymphotoxin in Namalwa KJM-1 cells adapted to serum-free medium.
Cytotechnology 4:39-43(1990)

DOI=10.1007/978-94-011-2044-9_9
Shinji Hosoi, Mitsuo Satoh, Hiromasa Miyaji, Tatsunari Nishi, Tamio Mizukami, Mamoru Hasegawa, Seiga Itoh, Tatsuya Tamaoki;
Stable production of pro-urokinase and its derivative by Namalwa KJM-1 cells adapted to a serum-free medium.
(In book chapter) Animal cell technology. Basic and applied aspects, Vol. 5; Kaminogawa, Shuichi & Ametani, Akio & Hachimura, Satoshi (eds.); pp.63-70; Springer; Dordrecht; Netherlands (1993)